DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Verma S, Miles D, Gianni L, Krop IE, Welslau M, Baselga J, Pegram M, Oh D-Y, Diéras V, Guardino E, Fang L, Lu M, Olsen S, and Blackwell K.
for the EMILIA Study Group. Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer.
N Engl J Med 2012;
367: 1783-1791
We do not assume any responsibility for the contents of the web pages of other providers.